<DOC>
	<DOC>NCT01801618</DOC>
	<brief_summary>Medium and long term efficacy of PI-based 2nd line antiretroviral (ARV) therapy in Cambodia is poorly documented when the numbers of patients on treatment and their duration are increasing. For patients in treatment failure , there is no alternative ARV regimen available to date. This operational research aims to evaluate the Cambodian National Program PI-based 2nd line antiretroviral regimen to assess the proportion of treatment failure and drug resistance ;identify the structural and individual factors associated with treatment failure ; design alternative salvage ARV regimens.</brief_summary>
	<brief_title>National Evaluation of PI-based 2nd Line Efficacy in Cambodia</brief_title>
	<detailed_description />
	<criteria>HIV infection age above 18 years current PI based 2nd line ARV treatment since at least 6 months willing to participate and consent signature ongoing PI based 2nd line regimen for less that 6 months at time of study intake</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>PI based 2nd line ARV treatment</keyword>
	<keyword>Virological failure</keyword>
	<keyword>Drug resistance</keyword>
	<keyword>Cambodia</keyword>
	<keyword>Adherence</keyword>
</DOC>